市場調查報告書
商品編碼
1138379
全球醫療輻射檢測、監測和安全市場-2022-2029Global Medical Radiation Detection, Monitoring & Safety Market - 2022-2029 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
醫療輻射檢測、監測和安全市場的增長主要受到放射治療和核能在各種疾病診斷中的使用增加的推動。
越來越多地使用放射療法和核電來診斷各種疾病,預計將推動市場的增長。
例如,根據世界核協會的數據,截至 2020 年 5 月,每年進行超過 4000 萬例核醫學手術,對放射性同位素的需求正以 5% 的速度增長。全球近 10,000 家醫院使用放射性同位素。僅在美國,每年就進行超過 2000 萬次核醫學研究。北美在診斷放射性同位素市場上占主導地位,佔歐洲之後的一半市場份額。
此外,越來越多的癌症患者、越來越多的影像中心以及人們日益提高的安全意識正在推動市場的增長。例如,各種類型的癌症都以細胞異常增殖為特徵。根據世界衛生組織的數據,男性在 75 歲時患癌症的機率為 14.4%,女性為 15.0%。根據 2013-2015 年的數據,大約 38.4% 的男性和女性將在其生命的某個階段被診斷出患有癌症。根據美國國家癌症中心,最常見的癌症(2018 年)是肺癌、乳腺癌、前列腺癌、皮膚黑色素瘤、結直腸癌、膀胱癌、非霍奇金淋巴瘤、腎和腎盂癌、子宮內膜癌、白血病、胰腺癌、甲狀腺癌和肝癌。此外,根據美國國家癌症中心的數據,2012 年約 57% 的新癌症病例發生在發展中地區,包括中美洲、非洲和亞洲部分地區,65% 的癌症死亡發生在這些地區。
缺乏或缺乏熟練的專業人員和嚴格的法規預計會阻礙市場增長。
然而,熟練專業人員的短缺和缺乏、嚴格的符合輻射使用安全的合規設備以及產品批准的延遲導致政府的嚴格監管減緩了市場的增長。這是一個障礙。訓練有素且稱職的醫學物理學家的數量仍達不到預期的要求。根據美國放射學會 (ABR) 的統計,從 2008 年到 2010 年,平均每年有 177 名醫學物理學家獲得董事會證書。 2016年,這一數字跌破200至196,2017年達到155。英國也缺乏放射科醫生。皇家放射科醫師學院 (RCR) 宣布,2019 年該國將至少短缺 1,100 名放射科醫師。
COVID-19 分析
COVID-19 大流行正在影響全球的醫療保健服務。由於大流行,世界上許多國家都推遲了非緊急成像手術。美國放射學院支持 CDC 建議的指導方針,建議醫療機構重新安排非緊急門診護理。非緊急程序包括篩查乳房 X 光檢查、肺癌篩查、非緊急計算機斷層掃描 (CT)、超聲、磁共振成像 (MRI)、平板 X 射線、其他非緊急或選擇性成像和透視,例如放射和放射指導檢查和程序。
行業分析
全球醫療輻射檢測、監測和安全市場受到各種行業因素的影響,例如波特五力、監管和報銷分析、供應鏈分析、定價分析、技術趨勢和進步、流行病學和未滿足的需求。我們提供基於對市場的深入分析。
全球醫療輻射檢測、監測和安全市場報告提供對大約 45 多個市場數據表、40 多個圖表和 180 頁的訪問。
Medical Radiation Detection, Monitoring & Safety Market size was valued US$ 1.0 billion in 2021 and is estimated to reach US$ 1.6 million by 2029, growing at a CAGR of 6.7% during the forecast period (2022-2029).
With the rising prevalence of cancer worldwide, diagnostic centers have started adopting the use of radiation therapies and nuclear medicines. These therapies release radioactive radiation, which is harmful to health and needs proper medical radiation detection, monitoring, and safety devices to radiation the environment's mediation. The radiation detection, monitoring & safety devices are mostly used in hospitals, ambulatory surgical centers (ASCs), and cancer centers.
The medical radiation detection, monitoring & safety market growth are majorly driven by the increasing use of radiation therapy and nuclear to diagnose various diseases.
Increasing use of radiation therapy and nuclear to diagnose various diseases are expected to drive market growth.
For instance, as per the World Nuclear Association, as of May 2020, over 40 million nuclear medicine procedures are performed annually, and the demand for radioisotopes is growing at a rate of 5%. Nearly 10,000 hospitals across the globe use them radioisotopes globe. In the US alone, annually, more than 20 million nuclear medicine procedures are performed. North America dominates the diagnostic radioisotopes market and accounts for half of the market share followed by Europe.
Besides, the rising number of cancer cases, an increase in the number of diagnostic imaging centers, and increasing safety awareness among people boost the market's growth. For instance, several different types of cancer are characterized by abnormal cell growth. According to WHO, the probability of developing cancer before age 75 is 14.4% in males and 15.0% in females. Based on data from 2013-2015, around 38.4% of men and women are diagnosed with cancer at some point during their lifetimes. As per the National Cancer Institute, the most common cancers (2018) are lung, breast cancer, prostate cancer melanoma of the skin, colon and rectum cancer, bladder cancer, non-Hodgkin lymphoma, kidney, and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer. Also, according to the National Cancer Institute, about 57% of new cancer cases in 2012 occurred in developing regions including Central America and parts of Africa and Asia; 65% of cancer deaths also occurred in these regions.
Lack and unavailability of skilled professionals, stringent regulation is expected to hamper the market growth.
However, the lack and unavailability of skilled professionals, stringent regulation compliance appliances for safety for radiation use, and delay in product approvals the government's stringent regulations government are factors hindering the market growth. The number of well-trained and competent medical physicists is still short of the desired requirement. According to the American Board of Radiology (ABR), between 2008 and 2010, on average, 177 medical physicists per year were given board certificates. In 2016, the number decreased below 200 to 196, and in 2017, it reached 155. The UK is also facing a shortage of radiologists. As per the Royal College of Radiologists (RCR), there is a shortage of at least 1,100 radiologists in the country in 2019.
COVID-19 Analysis
COVID-19 pandemic has impacted healthcare services globally. Many countries globally have seen non-urgent diagnostic imaging surgeries being postponed due to the pandemic. The American College of Radiation supports guidelines suggested by the CDC that advises medical facilities to reschedule non-urgent outpatient visits. Non-urgent procedures include non-urgent imaging and fluoroscopy procedures, such as screening mammography, lung cancer screening, non-urgent computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), plain film X-ray exams, and other non-emergent or elective radiologic and radiologically guided exams and procedures.
Industry Analysis
The global medical radiation detection, monitoring & safety market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces, Regulatory and Reimbursement Analysis, Supply Chain Analysis, Pricing Analysis, Technological Trends & Advancements, Epidemiology and Unmet Needs.
Full-body protection segment is expected to hold the largest market share in global medical radiation detection, monitoring & safety market
Based on safety products, the full-body protection segment accounted for the largest share of the medical radiation safety market in 2021. Medical radiation safety products include hand safety, full-body protection, face protection, and others. The full-body Protection segment accounted for the largest market share in 2021, owing to the increasing number of radiological procedures performed and rising awareness among physicians, radiologists, and patients. The extensive applications of full-body protection safety products such as aprons, barriers & shields lead to a higher adoption rate. The prices associated with the mobile lead barrier ranges from US$ 5,260 to US$ 7,820. On the other hand, the hand and face protection safety products are expected to grow significantly over the forecast period, due to the rising need for safety in radioactive emission & usage.
North America region holds the largest market share in the global medical radiation detection, monitoring & safety market
North America region is dominating the global medical radiation detection, monitoring & safety market accounting for the largest market share in 2021, owing to increasing awareness about radiation safety, a rising number of radio diagnostic procedures performed, and growing research and development of advanced radiation detection, monitoring, and safety products. Besides, due to the rising prevalence of cancer globally, diagnostic centres have adopted the use of radiation therapies and nuclear medicines. In the United States, colorectal cancer is the third leading cause of cancer-related deaths in men and women, and the second most common cause of cancer deaths combined globally. It is expected to about 106,180 new cases of colon cancer, 44,850 new cases of rectal cancer during 2022. he diagnosed incident colorectal cancer cases are expected to increase by 27.3% to 672,400 cases by 2037. In Mexico, cancer currently is one of the largest challenges in public health. According to the Cancer Statistics Center, there were 11,030 new cases were estimated in Mexico in 2022.
The medical radiation detection, monitoring & safety market is highly fragmented and consists of a large number of players. Some of the key players which are contributing to the growth of the market are Fortive Corporation, Mirion Technologies, IBA Worldwide, Thermo Fisher Scientific, Sun Nuclear Corporation, Bertin Instruments, Radiation Detection Company Inc, Biodex Medical Systems, Inc, Centronic Ltd, Ludlum Measurements, Inc among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the medical radiation detection, monitoring & safety market globally. For instance,
In May 2019, Kromek had launched a new D3S SPRD (spectroscopic radiation detector) Personal Radiation Detector. It is palm size and a very cost-effective radioactive detection device. It can be connected and displayed on the mobile phone which makes it more effective. This product launch had expanded the product portfolio of the company.
In March 2019, Arktis Radiation Detectors Ltd had developed new flat panel gamma (FPG) detector. This detector will significantly improve the capability of detecting radioactive materials in various applications. These developments in the product have seen a positive response from their customers and have increased their sales and have expanded the customer base.
In March 2019, Thermo Fisher Scientific launched a new dosimetry monitoring service that enables medical and imaging facilities, dental offices, veterinary clinics, nuclear power plants, laboratories, and other facilities with radiation safety requirements to streamline the management of their safety programs.
In 2019, IBA Worldwide launched my iON, offering a unique environment for fast and precise cancer patient QA in proton therapy.
Overview: Fortive is an American diversified industrial technology conglomerate company headquartered in Everett, Washington. Fortive was spun off from Danaher in July 2016. Mitchell Rales and Steven M. Rales, Danaher's founders, retained board seats with Fortive after the separation.
Colposcope CARL ZEISS KSK 150 FC: The Zeiss KSK is mobile colposcope that is equipped with video track for clear imaging and observation. It gives a proper and clear view of vulva, vagina and cervix. It supports illumination and magnification.
Key Developments: In 2019, ZEISS acquired Brunswick based GOM.
The global medical radiation detection, monitoring & safety market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.